FDA product code QHA: X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
QHA is the FDA product code for x-ray angiographic imaging based coronary vascular simulation software device. It is a Class II device, regulated under 21 CFR 892.1600 and reviewed by the Radiology panel. FDA has cleared 7 510(k) submissions under QHA, 5 in the last five years, from 5 different applicants. The average 510(k) review took 190 days (median 239); 204 days on average over the last three years.
Definition
X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
Classification
| Field | Value |
|---|---|
| Device name | X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device |
| Device class | Class II |
| Regulation | 21 CFR 892.1600 |
| Review panel | RA — Radiology |
| Medical specialty | Radiology |
| Premarket route | 510(k) |
510(k) clearances per year for QHA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 251 |
| 2021 | 1 | 239 |
| 2023 | 2 | 144 |
| 2024 | 1 | 265 |
| 2025 | 2 | 144 |
Compare with all 510(k) review times · Search every QHA clearance
Top QHA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| ArteryFlow Technology Co., Ltd. | 3 | 2023-03-02 |
| Spectrawave, Inc. | 1 | 2025-10-17 |
| Qfr Solutions BV | 1 | 2025-04-04 |
| Pie Medical Imaging BV | 1 | 2024-04-09 |
| Medis Medical Imaging Systems BV | 1 | 2019-05-30 |
Most recent QHA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K251355 | Spectrawave, Inc. | X1-FFR | 2025-10-17 | 170 |
| K243769 | Qfr Solutions BV | QFR (3.0) | 2025-04-04 | 119 |
| K232147 | Pie Medical Imaging BV | CAAS Workstation | 2024-04-09 | 265 |
| K230303 | ArteryFlow Technology Co., Ltd. | AccuFFRangio Plus | 2023-03-02 | 27 |
| K221711 | ArteryFlow Technology Co., Ltd. | AccuICAS | 2023-02-28 | 260 |
Recalls for QHA devices
FDA recall records list no recalls for product code QHA.
Frequently asked questions
What is FDA product code QHA?
QHA is the FDA product code for x-ray angiographic imaging based coronary vascular simulation software device. It is a Class II device, regulated under 21 CFR 892.1600 and reviewed by the Radiology panel.
What device class is QHA?
Class II, regulation 21 CFR 892.1600. Typical premarket route: 510(k).
How long does a 510(k) take for product code QHA?
Across 7 cleared submissions the average was 190 days from receipt to decision (median 239).
Which companies have the most QHA clearances?
ArteryFlow Technology Co., Ltd. (3); Spectrawave, Inc. (1); Qfr Solutions BV (1); Pie Medical Imaging BV (1); Medis Medical Imaging Systems BV (1).
Next steps
- Run an FDA pathway report with predicate devices for product code QHA
- Run a recall and safety report across every QHA manufacturer
- Watch product code QHA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Radiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times